Vimta Labs released the Q4 FY26 earnings call transcript, noting outsourcing-driven growth across pharma and related testing segments, improving visibility, and a shift toward large-molecule R&D with broader overseas opportunities.
AI Assistant
Vimta Labs Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.